Antibody dynamics of 2009 influenza A (H1N1) virus in infected patients and vaccinated people in China

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Wang, Ming ^a   Yuan, Jun ^a   Li, Tiegang ^a   Liu, Yang ^a   Wu, Jibin ^a   Di, Biao ^a   Chen, Xi ^a   Xu, Xinhong ^a   Lu, Enjie ^a   Li, Kuibiao ^a   Liu, Yanhui ^a   Wu, Yejian ^a   Chen, Xiongfei ^a   He, Peng ^a   Wang, Yulin ^a   Liu, Jianhua ^a  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHINA; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; REVACCINATION; RISK ASSESSMENT; SEROCONVERSION; VIRUS ISOLATION; VIRUS STRAIN; BLOOD; EPIDEMIC; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MIDDLE AGED; RECURRENT DISEASE; RISK; VACCINATION;

INFLUENZA A VIRUS;

ADULT; ANTIBODIES, VIRAL; CHINA; DISEASE OUTBREAKS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; RECURRENCE; RISK; VACCINATION; YOUNG ADULT;

EID: 79951808174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016809     Document Type: Article

References (14)

1. WHO (2010) In focus: H1N1 now in the post-pandemic period. 10 August 2010. Available: http://www.who.int/csr/disease/swineflu/en/. Accessed 4 September 2010.
2. WHO (2010) Director-General statement following the seventh meeting of the Emergency Committee. 24 February 2010. Available: http://www.who.int/csr/disease/swineflu/7th_meeting_ihr/en/. Accessed 5 July 2010.
3. Wang M, Di B, Zhou DH, Zheng BJ, Jing H, et al. (2006) Food markets with live birds as source of avian influenza. Emerg Infect Dis 12: 1773-5.
4. Wang M, Fu CX, Zheng BJ, (2009) Antibodies against H5 and H9 avian influenza among poultry workers in China. N Engl J Med 360: 2583-4.
5. Girard MP, Tam JS, Assossou OM, Kieny MP, (2010) The 2009 A (H1N1) influenza virus pandemic: A review. Vaccine 28: 4895-4902.
6. Plennevaux E, Sheldon E, Blatter M, Reeves-Hoché MK, Denis M, (2009) Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 375: 41-8.
7. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, et al. (2009) Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 361: 2405-13.
8. Bernstein DI, Zahradnik JM, DeAngelis CJ, Cherry JD, (1982) Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months. Pediatrics 69: 404-8.
9. Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, et al. (2000) Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 136: 168-75.
10. Kilbourne, D E, (1976) Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans. J Infect Dis 134: 384-94.
11. Sasaki S, Jaimes MC, Holmes TH, Dekker CL, Mahmood K, et al. (2007) Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 81: 215-28.
12. Clements ML, Murphy BR, (1986) Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol 23: 66-72.
13. Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, et al. (2009) A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 361: 2414-23.
14. Perez CM, Ferres M, Labarca JA, (2010) Pandemic (H1N1) 2009 reinfection, Chile. Emerg Infect Dis 16: 156-7.